Study of small liver grafts for portal hypertension treatment
Part of Digestive system clinical trials.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 14 years.
- You have decompensated portal hypertension (advanced liver disease with complications).
- You are already a candidate for a liver transplant.
- Your INR (blood clotting test) must be below 2.4.
- You are scheduled for a partial or full liver transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a temporary surgical bypass during liver transplantation to improve how well the new liver works, especially when the donor liver is “extended criteria.” It may help patients whose transplant plan includes a higher-risk donor liver by testing whether the bypass better protects the graft.
This trial tests a procedure to lower blood loss during liver transplant for patients with high blood pressure in the liver. It may help those who have had a previous transplant, abdominal surgery, or certain complications of liver disease.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This trial tests whether a medication (octreotide) or a minor surgical procedure (tying off a spleen artery) works better to help a smaller-than-ideal liver graft work well after a living donor transplant. The goal is to improve blood flow and prevent complications.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
This trial tests a special stent to treat high blood pressure in the liver caused by cirrhosis. It may help patients who need a procedure called TIPS to improve blood flow.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.